Victoria Ortín Piqueras

Dr. Victoria Ortín Piqueras

University of Helsinki
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Veterinary Microbiology
Verified
Journal Article
Closed access
VWVictoria E. Watson
Victoria E. Watson
MJMegan E. Jacob
Megan E. Jacob
JBJosé M. Bruno-Bárcena
José M. Bruno-Bárcena
SASophia Amirsultan
Sophia Amirsultan
SSStephen H. Stauffer
Stephen H. Stauffer
JGJody L. Gookin
Jody L. Gookin

9 August 2016 in Amino Acids
Verified
Journal Article
Closed access
PDF file
SKSuvi Kalliokoski
Suvi Kalliokoski
Victoria Ortín PiquerasVictoria Ortín Piqueras
Victoria Ortín Piqueras
RFRafael Frías
Rafael Frías
ASAna-Marija Sulic
Ana-Marija Sulic
JMJuha A. E. Määttä
Juha A. E. Määttä
KLKatri Lindfors
Katri Lindfors

1 July 2020 in Journal of Exotic Pet Medicine
Verified
Journal Article
Open access
FWFranziska R. Wilhelm
Franziska R. Wilhelm
MKMaria-E. Krautwald-Junghanns
Maria-E. Krautwald-Junghanns
Victoria Ortín PiquerasVictoria Ortín Piqueras
Victoria Ortín Piqueras
JJJouni JT Junnila
Jouni JT Junnila
KCKerstin Cramer
Kerstin Cramer
VSVolker Schmidt
Volker Schmidt
Background: Iohexol has been successfully used as a marker to assess intestinal permeability in humans and various other mammals. The objective of this study was to evaluate the use of oral iohexol as an intestinal permeability marker in four anatomically and nutritionally diverse bird species. Methods: Three dosages (1 ml/kg, 2 ml/kg, 4 ml/kg) of iohexol (755 mg/ml) were administered orally to each six clinically healthy pigeons and chickens at two-week intervals. Iohexol plasma concentration was determined 45, 90 and 180 minutes after administration. A comparative study was performed by administering iohexol twice to each six clinically healthy cockatiels and falcons, and determining iohexol plasma concentration at 45 or 90 minutes after administration. Results: The recommended iohexol dosage for permeability testing in birds was determined to be 1 ml/kg. Median plasma iohexol concentrations were 27.77 µg/ml in pigeons, 12.97 µg/ml in chickens, 14.24 µg/ml in cockatiels, and 47.81 µg/ml in falcons, 45 minutes after this dosage was administered. At 90 minutes after administration, median plasma iohexol concentrations were 40.68 µg/ml in pigeons, 21.59 µg/ml in chickens, 32.03 µg/ml in cockatiels, and 55.96 µg/ml in falcons. Conclusions and clinical relevance: Oral iohexol was a safe and feasible marker for intestinal permeability assessment in birds. Further investigations are warranted to establish species-specific reference intervals in larger numbers of healthy birds, and to examine the use of iohexol as a permeability marker in birds with disorders associated with altered intestinal permeability.

4 January 2021 in Animals
Verified
Journal Article
Open access
PDF file
Victoria Ortín PiquerasVictoria Ortín Piqueras
Victoria Ortín Piqueras
TFTobias L Freitag
Tobias L Freitag
LALeif C Andersson
Leif C Andersson
SLSanna Lehtonen
Sanna Lehtonen
SMSeppo K Meri
Seppo K Meri
RFRafael Frias
Rafael Frias
Intestinal permeability (IP) tests are used to assess intestinal damage in patients and research models. The probe iohexol has shown advantages compared to 51Cr-EDTA or absorbable/nonabsorbable sugars. During IP tests, animals are housed in metabolic cages (MCs) to collect urine. We examined the performance of an iohexol IP test in mice. Rag1-/- (C57BL/6) mice of both sexes were divided into controls or treatment groups, the latter receiving injections of effector/memory T cells to induce intestinal inflammation. After two, four and five weeks (W), a single dose of iohexol was orally administered. Urine was collected seven times over 24 h in MCs. Iohexol concentration was measured by ELISA. Intestinal histological damage was scored in duodenal sections. In control and treated mice of both sexes, urinary excretion of iohexol peaked at 4 h. From W2 to W4/W5, urinary iohexol excretion increased in treated mice of both sexes, consistent with development of duodenitis in this model. Positive correlations were observed between the urinary excretion of iohexol in W4/W5 and the histological severity of duodenitis in treated male mice. We conclude that a 6 h cumulative urine sample appears sufficient to evaluate small IP to iohexol in this mouse model, improving animal welfare by reducing cage periods.